Nathan v. Takeda Pharmaceuticals America, Inc.

890 F. Supp. 2d 629, 2012 WL 3686737, 2012 U.S. Dist. LEXIS 120705
CourtDistrict Court, E.D. Virginia
DecidedAugust 24, 2012
DocketCase No. 1:11-cv-1360 (AJT/TRJ)
StatusPublished
Cited by10 cases

This text of 890 F. Supp. 2d 629 (Nathan v. Takeda Pharmaceuticals America, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nathan v. Takeda Pharmaceuticals America, Inc., 890 F. Supp. 2d 629, 2012 WL 3686737, 2012 U.S. Dist. LEXIS 120705 (E.D. Va. 2012).

Opinion

MEMORANDUM OPINION

ANTHONY J. TRENGA, District Judge.

Plaintiff Noah Nathan (“Nathan”) claims that because of his child-care duties, defendants Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals North America, Inc. (collectively referred to as “Takeda”) discriminated against him and subjected him to a hostile work environment, and also retaliated against him for complaining about his mistreatment, all in violation of Title VII of the Civil Rights Act of 1964, 42 U.S.C. § 2000e, et seq. This matter is before the Court on defendants’ Motion for Summary Judgment. For the reasons stated herein, the Court grants defendants’ motion.

[633]*633I. FACTS.1

Nathan began his employment with Takeda in 2002 and became a specialty sales representative in 2004, the position he held at the time that Takeda engaged in the allegedly illegal conduct. As a specialty sale representative, his job was to promote the sale of Takeda pharmaceuticals to health professionals. As a part of his duties, he was required to spend most of his time visiting various medical offices in his territory in order to provide health care professionals with information about drugs that Takeda manufactures. For this reason, specialty sales representatives work “in the field” and also from their home offices.

Specialty sales representatives are supervised by district managers, who, among other activities, participate in “ride along” days where they accompany a sales representative during his customer visits in order to observe that representative’s interactions with health care professionals. Takeda also requires its sales representatives to be “certified” by Takeda to sell its drugs, including each new drug that Takeda releases. Takeda provides training to sales representatives for that purpose, including a performance improvement plan (usually created in consultation with both the sales representative’s District Manager, the Regional Manager, and the Human Resources department) when a sales representative does not meet expectations after a certain point in his training.

The events that give rise to Nathan’s claims began in the latter half of 2008. At that time, Nathan’s district manager was Michael Fouchie. Fouchie expected all of his representatives in his district to start their work day in the field at 8:00 a.m. However, under an arrangement with his wife, Nathan dropped his older child off at school Tuesday through Friday at 8:30 a.m., following which he would begin his work day. Def.’s Ex. C, at 105-06 (“Nathan Dep.”); SUF 16. Fouchie occasionally commented critically to Nathan about his start times, but in November 2008 the criticism escalated. Id. at 106-07. During a conversation with Nathan about his start times on November 20, 2008, Fouchie learned that Nathan’s tardiness was due to his child-care responsibilities four days per week. SUF 16. During that conversation, Fouchie told Nathan that starting his field work at 8:30 a.m. on a regular basis was not acceptable. Id. Fouchie also asked Nathan why his wife could not drop their older child off at school, a comment that became the basis for Nathan’s claims of gender discrimination. According to Nathan, Fouchie “had the attitude where it’s the wife’s job to do it, how come your wife can’t do it,” though Nathan does not point to any other actual statements by Fouchie to support that “attitude.”

Nathan spoke with other sale representative supervised by Fouchie and found that Fouchie applied his start-time policy uniformly throughout his sales district.2 [634]*634Nathan Dep. 130-33. In fact, Fouehie had sent an email to the entire sales force in his district telling the sales representatives to start by 8:00 a.m. because he wanted to be able to boast that his sales representatives were in the field early. SUF 17.

Fouchie’s comments to Nathan about Fouchie’s start-time policy continued after November 20, 2008, but without any explicit reference to his wife. In an e-mail dated December 12, 2008, Fouehie told Nathan the following:

I want to follow up on our conversation on November 20 about you having to start work after 8:30 am everyday because you have to drop off your child at school at 8:30 am since they started in a new school. I fully support work life balance and expect that you strive to achieve it. In my opinion consistently starting at 8:30 am is not reasonable and fair to Takeda or me.
“The expectation is your first call of the day should be to an office within your routing that opens the earliest of that day ... and the last call of the day should be to an office that closes the latest that day .... ”
Please communicate with me when you need to occasionally start late or finish early and I will support your reasonable requests. There are times when you need to start later and finish earlier. (i.e. Doctor and Dentist appointments or taking a child to doctor.)
Please help me understand what solution you have come up with to address your start times to put them in line with expectations; I want you to have some flexibility and appreciate your answering honestly when I asked about start times.
Let’s find a solution that is a win for everyone ....

Nathan Dep. Ex. 7. The record contains no other specific exchanges over the start-time policy until two months later in February 2009.

On February 2, 2009, Nathan attended a national company meeting in Anaheim, California related to Takeda’s market introduction of two new drugs: Uloric and Kapidex. Consistent with its established policy, Takeda required its entire sales force to be certified on Uloric and Kapidex. For that purpose, Takeda prepared sales materials on these drugs and the Anaheim meeting was devoted to certifying sales representatives on those two new drugs. Nathan participated in these certification exercises in Anaheim; and Fouehie certified Nathan on both drugs.3 After the Anaheim meeting, Fouehie informed his supervisor, the Regional Sales Manager Louis Savant, that he had certified some of his sales representatives in Anaheim, but believed that Nathan and another sales representative required more training before selling Kapidex and Uloric.4

[635]*635On February 9, 2009, Fouchie called Nathan, and in response to Fouchie’s question, Nathan confirmed that he had the same arrangement for taking his older child to school in the morning. Nathan Dep. 127. That same day, Fouchie notified Takeda’s training department that he needed assistance with the certification of Nathan and another sales representative;5 and later that same day, Fouchie told Nathan he needed to be recertified on Uloric. Also on February 9, 2009, following his conversation with Fouchie, Nathan contacted Cassandra Smith of Takeda’s Human Resources Department (“HR”) and complained that he was being discriminated against because of his family responsibilities.6 Specifically, he complained that he was being singled out for failing to comply with morning start times because of his family responsibilities to take his children to school.

On February 11, 2009 around 5:00 p.m., Fouchie, by e-mail, directed Nathan to meet him the next morning at 7:00 a.m.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hall v. Sizewise Rentals LLC
D. South Carolina, 2025
Williams v. Fairfax County
E.D. Virginia, 2022
Tedder v. CareSouth Carolina Inc
D. South Carolina, 2022
Phillips v. WakeMed
E.D. North Carolina, 2021
Walker v. Mod-U-Kraf Homes, LLC
988 F. Supp. 2d 589 (W.D. Virginia, 2013)
Nathan v. Takeda Pharmaceuticals America, Inc.
546 F. App'x 176 (Fourth Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
890 F. Supp. 2d 629, 2012 WL 3686737, 2012 U.S. Dist. LEXIS 120705, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nathan-v-takeda-pharmaceuticals-america-inc-vaed-2012.